SCHEMBL176077

SCHEMBL176077

C=CCC1(N)CCCCC1

nearest known ligand 0.35

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.31
ALDH1A1 P00352 1/20 0.31
POLB P06746 1/20 0.31
KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1485741 1.00 MEN1 (0.31) MEN1ALDH1A1POLBKMT2A
SCHEMBL7561906 1.00 MEN1 (0.31) MEN1ALDH1A1POLBKMT2A
SCHEMBL7561639 1.00 MEN1 (0.31) MEN1ALDH1A1POLBKMT2A
SCHEMBL975449 0.97
SCHEMBL8926772 0.86
SCHEMBL20198621 0.84
SCHEMBL3216036 0.78 TSHR (0.35)
SCHEMBL29662729 0.75
SCHEMBL7421378 0.75
SCHEMBL2995744 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1290 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4728031-A1 POLYMERIC SOOT DISPERSANT Chevron Oronite Company LLC (US) 2026-04-22 EP claimed
EP-4728030-A1 LOW MOLECULAR WEIGHT POLYMERIC SOOT DISPERSANT Chevron Oronite Company LLC (US) 2026-04-22 EP claimed
WO-2024259449-A1 POLYMERIC SOOT DISPERSANT CHEVRON ORONITE COMPANY LLC (US) 2024-12-19 WO claimed
WO-2024259451-A1 LOW MOLECULAR WEIGHT POLYMERIC SOOT DISPERSANT CHEVRON ORONITE COMPANY LLC (US) 2024-12-19 WO claimed
CN-117510958-A Method for manufacturing super-hydrophobic PMMA material and super-hydrophobic PMMA material 浙江华帅特新材料科技有限公司 2024-02-06 CN claimed
CN-106459803-B Urea-based grease 出光兴产株式会社 2021-05-04 CN claimed
CN-110922728-A Organic nucleating agent for preparing heat-resistant polylactic resin and preparation method thereof 蚌埠学院 2020-03-27 CN claimed
US-10086339-B2 Polymers and membranes for separation of polar organic compounds from aqueous mixtures and methods of using THE UNIVERSITY OF CONNECTICUT (US) 2018-10-02 US claimed
CN-105899494-B The Gd coordination compound of the conjugate of tranexamic acid containing DO3A- 韩国庆北国立大学产业学术合作基金会 2018-06-15 CN claimed
US-20170027885-A1 1-AMINOCYCLOHEXANE DERIVATIVES FOR THE TREATMENT OF COCHLEAR TINNITUS MERZ PHARMA GMBH & CO. KGAA (DE) 2017-02-02 US claimed
WO-2004009062-A2 NMDA RECEPTOR ANTAGONISTS AND THEIR USE IN INHIBITING ABNORMAL HYPERPHOSPHORYLATION OF MICROTUBULE ASSOCIATED PROTEIN tau IQBAL KHALID (US) 2004-01-29 WO claimed
CN-1136187-C 1-amino-alkylcyclohexane NMDA receptor antagonists Ī�Ĺɷݹ�˾ 2004-01-28 CN claimed
CN-1461213-A 1-amino-alkylcyclohexanes as trypanocidal agents MERZ & CO GMBH & CO (DE) 2003-12-10 CN claimed
JP-2003513083-A 2003-04-08 JP claimed
EP-1228052-A1 1-CYCLIC AMINO-ALKYLCYCLOHEXANE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR USE AS ANTICONVULSANTS Merz Pharmaceuticals GmbH (DE) 2002-08-07 EP claimed
EP-0808828-B1 Carbodiimide having double bonds NISSHIN SPINNING (JP) 2001-12-12 EP claimed
WO-2001032640-A1 1-CYCLIC AMINO-ALKYLCYCLOHEXANE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR USE AS ANTICONVULSANTS MERZ PHARMACEUTICALS GMBH (DE) 2001-05-10 WO claimed
CN-1266423-A 1-amino-alkylcyclohexane NMDA receptor antagonists MERZ & CO GMBH & CO (DE) 2000-09-13 CN claimed
EP-0808828-A2 Carbodiimide having double bonds NISSHINBO INDUSTRIES, INC. (JP) 1997-11-26 EP claimed
US-4975512-A Crosslinking with amine, ammonium, hydrazine PETROLEUM ENERGY CENTER (JP) 1990-12-04 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170027885-A1 1-AMINOCYCLOHEXANE DERIVATIVES FOR THE TREATMENT OF COCHLEAR TINNITUS OTC, CNR2, CNR1 MEN1 332/4885ALDH1A1 740/4885POLB 2686/4885
US-10086339-B2 Polymers and membranes for separation of polar organic compounds from aqueous mixtures and methods of using PHOSPHO1, PEF1, PORCN MEN1 459/4885ALDH1A1 2370/4885POLB 326/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.